Publikationen von Martin Begemann
Alle Typen
Zeitschriftenartikel (54)
41.
Zeitschriftenartikel
13, 218 (2013)
Odor naming and interpretation performance in 881 schizophrenia subjects: association with clinical parameters. BMC Psychiatry 42.
Zeitschriftenartikel
19, S. 135 - 148 (2013)
Genetic markers of Munc13 protein family member, BAIAP3, are gender-specifically associated with anxiety and benzodiazepine abuse in mouse and man. Molecular Medicine 43.
Zeitschriftenartikel
3, e254 (2013)
A single gene defect causing claustrophobia. Translational Psychiatry 44.
Zeitschriftenartikel
4 (6), S. 528 - 539 (2012)
A myelin gene causative of a catatonia-depression syndrome upon aging. Embo Molecular Medicine 45.
Zeitschriftenartikel
18, S. 1029 - 1040 (2012)
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Molecular Medicine 46.
Zeitschriftenartikel
Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia. Translational Psychiatry, e45 (2011)
47.
Zeitschriftenartikel
68 (12), S. 1247 - 1256 (2011)
Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Archives of General Psychiatry 48.
Zeitschriftenartikel
156 (3), S. 340 - 345 (2011)
A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 49.
Zeitschriftenartikel
3 (6), S. 309 - 319 (2011)
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. Embo Molecular Medicine 50.
Zeitschriftenartikel
16 (1), S. 26 - 36 (2011)
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Molecular Psychiatry 51.
Zeitschriftenartikel
16, 1 (2011)
EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Molecular Psychiatry 52.
Zeitschriftenartikel
10, 91 (2010)
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 53.
Zeitschriftenartikel
67 (9), S. 879 - 888 (2010)
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Archives of General Psychiatry 54.
Zeitschriftenartikel
14 (9-10), S. 546 - 552 (2008)
Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Molecular Medicine